RVL Pharmaceuticals PLC (NASDAQ:RVLP)

Delayed Data
As of Jun 08
 -0.0025 / -0.30%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for RVL Pharmaceuticals PLC have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 1.00. The median estimate represents a +261.40% increase from the last price of 0.83.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in RVL Pharmaceuticals PLC. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.25%
Growthannually 31.47%


Growthquarterly 23.44%
Growthannually -0.31%
Key to the earnings and sales forecast charts.